Business Standard

Saturday, February 08, 2025 | 04:41 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Zydus receives USFDA tentative approval for Lorcaserin Hydrochloride Tablet

Image

Capital Market
Zydus Cadila has received the tentative approval from the USFDA to market Lorcaserin Hydrochloride Tablets (US RLD Belviq Tablets), 10 mg. The drug is used together with diet and exercise to treat obesity. It will be manufactured at the group's formulations manufacturing facility at SEZ.

The group now has 278 approvals and has so far filed over 330 ANDAS since the commencement of the filing process in FY 2003-04.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 03 2019 | 1:14 PM IST

Explore News